What’s Fueling DexCom Inc (DXCM) Stock’s -22.52% Loss Below Its 200-Day SMA?

Robert W. Baird has recently reduced DexCom Inc (DXCM) stock to Neutral rating, as announced on July 26, 2024, according to Finviz. Earlier, on July 26, 2024, JP Morgan had reduced the stock from a Overweight to Neutral, setting a price target of $75 for DXCM stock. Redburn Atlantic also initiated Neutral rating with a […]

What’s Behind the -1.04% Drop in DexCom Inc (DXCM) Stock? Find Out Now!

Robert W. Baird has recently reduced DexCom Inc (DXCM) stock to Neutral rating, as announced on July 26, 2024, according to Finviz. Earlier, on July 26, 2024, JP Morgan had reduced the stock from a Overweight to Neutral, setting a price target of $75 for DXCM stock. Redburn Atlantic also initiated Neutral rating with a […]

What’s Fueling DexCom Inc (DXCM) Stock’s -26.73% Loss Below Its 200-Day SMA?

Robert W. Baird has recently reduced DexCom Inc (DXCM) stock to Neutral rating, as announced on July 26, 2024, according to Finviz. Earlier, on July 26, 2024, JP Morgan had reduced the stock from a Overweight to Neutral, setting a price target of $75 for DXCM stock. Redburn Atlantic also initiated Neutral rating with a […]

Why Did Robert W. Baird Give DexCom Inc (DXCM) Stock Neutral Rating?

Robert W. Baird has recently reduced DexCom Inc (DXCM) stock to Neutral rating, as announced on July 26, 2024, according to Finviz. Earlier, on July 26, 2024, JP Morgan had reduced the stock from a Overweight to Neutral, setting a price target of $75 for DXCM stock. Redburn Atlantic also initiated Neutral rating with a […]

DexCom Inc (DXCM) Stock Rated Neutral by Robert W. Baird

Robert W. Baird has recently reduced DexCom Inc (DXCM) stock to Neutral rating, as announced on July 26, 2024, according to Finviz. Earlier, on July 26, 2024, JP Morgan had reduced the stock from a Overweight to Neutral, setting a price target of $75 for DXCM stock. Redburn Atlantic also initiated Neutral rating with a […]

Why Did DexCom Inc (DXCM) Stock See -1.84% Plunge in the Last 90 Days?

Robert W. Baird has recently reduced DexCom Inc (DXCM) stock to Neutral rating, as announced on July 26, 2024, according to Finviz. Earlier, on July 26, 2024, JP Morgan had reduced the stock from a Overweight to Neutral, setting a price target of $75 for DXCM stock. Redburn Atlantic also initiated Neutral rating with a […]